Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Anshen Dingzhi granule is a Traditional Chinese Medicine (TCM) formulation primarily used to treat generalized anxiety disorder (GAD), insomnia, and palpitations. It is based on the classic Anshen Dingzhi formula, which is traditionally indicated for the Heart and Gallbladder Qi Deficiency syndrome. The preparation typically consists of several botanical and mineral components, including *Poria cocos*, *Polygala tenuifolia*, *Acorus tatarinowii*, and *Panax ginseng*. It is currently being evaluated in clinical trials, such as those sponsored by Xuanwu Hospital of Capital Medical University, to optimize TCM regimens for GAD by comparing its efficacy and safety against conventional treatments like buspirone.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Anshen Dingzhi granule.